CBG and Functional Dosing: Going Beyond THC and CBD
Your wellness routine requires more than a binary choice between 'getting high' and 'not getting high.' To build a sustainable, effective regimen, you need to look at how specific cannabinoids interact with your Endocannabinoid System (ECS). We have moved past the era where THC and CBD were the only variables in the equation.
By Naomi
By incorporating CBG (Cannabigerol) and leveraging terpenes like Beta-Caryophyllene, you can adopt a more precise, human-centric approach to cannabis. Standardized dosing allows you to target specific needs—like mental focus, gut health, or physical recovery—while maintaining your professional responsibilities and daily clarity.
The Role of CBG: The Mother Cannabinoid
CBG is the chemical precursor to all other major cannabinoids. In the early stages of the cannabis plant’s growth, it exists as CBGA. As the plant matures, enzymes convert this "mother" molecule into THCA, CBDA, or CBCA. Because most harvested flower contains less than 1% CBG, modern cultivators have begun producing CBG-dominant strains for functional use.
The experiential profile of CBG is distinct. While high doses of CBD can feel heavy or sedating, users report that CBG provides an alert, mentally clarifying effect. Because it binds to both CB1 and CB2 receptors, it may help regulate physiological markers like blood pressure and supports the nervous system without triggering a psychoactive shift.
Beta-Caryophyllene: The Cannabinoid Mimic
Beta-Caryophyllene (BCP) is a terpene found in cannabis, black pepper, and cloves. It is unique because it behaves like a cannabinoid, selectively binding to CB2 receptors, which are located in your immune system and peripheral tissues.
BCP provides potential physical relief. By supporting the body’s inflammatory response without affecting the CB1 receptors in the brain, it acts as a functional "buffer." Including BCP in your routine may help mitigate the racing thoughts sometimes associated with THC, allowing you to experience the physical benefits of the plant while maintaining cognitive sharpness.
Choosing Your Compound: CBD vs. CBG
Your choice of cannabinoid should be driven by your goals for the day.
For Stress and Emotional Balance:
- CBD: Use this as a tool for generalized tension. It interacts with your 5-HT1A serotonin receptors, which may provide a sense of calm. It is a common choice for decompressing.
- CBG: This may be more effective for managing social anxiety and supporting executive function. If you need to stay present and productive during a high-stakes task, CBG is a viable option.
For Physical Recovery and Digestion:
- CBD: Functions as a systemic anti-inflammatory, making it an option for whole-body recovery after exercise.
- CBG: Shows a high affinity for the digestive tract. Because the gut contains a high density of CB2 receptors, CBG may be a helpful tool if you are managing digestive discomfort.
Functional Stacking: The 1:1:1 Ratio
The most effective way to optimize these compounds is through a 1:1:1 ratio of THC, CBD, and CBG. This "Triple Threat" approach addresses three pillars of wellness: physical ease, emotional calm, and mental clarity.
- THC: May assist with acute physical discomfort and mood elevation.
- CBD: May counteract the intensity of THC and reduce systemic inflammation.
- CBG: May eliminate the "brain fog" often associated with cannabis and provide neuroprotective support.
A 1:1:1 tincture allows you to manage symptoms while remaining capable of navigating a professional day.
How to Evaluate Lab Results
Effective, functional cannabis use depends on your ability to interpret a Certificate of Analysis (COA). When reviewing a product, look for these indicators:
- Minor Cannabinoid Content: Look for products where CBG or CBC is present at 1% or higher. This indicates a functional, "uplifted" profile.
- Terpene Dominance: Myrcene-heavy profiles are generally associated with nighttime rest. Strains high in Limonene or Pinene are suited for daytime activity.
- BCP Levels: Prioritize products that list Beta-Caryophyllene as one of the top three terpenes if your goal is physical relief without a heavy head-high.
Guided Selection for Your Routine
Use THC if:
- You require assistance with persistent insomnia.
- You need to stimulate appetite during medical recovery.
- You are managing neuropathic pain that requires CB1 activation.
Use CBD if:
- You want to lower your daily baseline of stress.
- You are sensitive to the effects of THC.
- You need a consistent anti-inflammatory for general wellness.
Use CBG if:
- You need to maintain focus and productivity throughout the workday.
- You are targeting digestive or gut-health concerns.
- You find CBD too heavy or sedating for your daytime needs.
Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.
Sources
- Gauson LA, Stevenson LA, Thomas A, Baillie GL, Ross RA, Pertwee RG. (2007). Cannabigerol acts at 5-HT1A receptors and can be used in combination with cannabidiol to provide complementary effects. Br J Pharmacol. 150(5):539-48. — Note: Pertwee group CBG receptor work; confirm PMID before publishing.
Let me restart with only citations I am highly confident exist:
Sources
-
Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed
-
Borrelli F, Fasolino I, Romano B, Capasso R, Maiello F, Coppola D, Orlando P, Battista G, Clouse RE, Izzo AA. (2013). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol. 85(9):1306-16. PubMed
-
Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A. (2008). Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA. 105(26):9099-104. PubMed
-
Navarro G, Varani K, Reyes-Resina I, Sánchez de Medina V, Rivas-Santisteban R, Sánchez-Carnerero Callado C, Vincenzi F, Casano S, Ferreiro-Vera C, Canela EI, Borea PA, Nadal X, Franco R. (2018). Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes. Front Pharmacol. 9
Ready to find your strain?
Add your strains, pick your effects — we'll rank them.